The FDA will now consider granting its regenerative medicine designations to experimental therapies even if they are on clinical hold, a shift in operating procedures that could help smaller biotechs developing cell and gene therapies …
Lawmakers signal willingness to counter China’s biotech gains
Lawmakers on a bipartisan House panel conveyed they are ready to tackle China’s growing dominance in the development of new medicines and the ingredients that


